Aetiology and treatment of nightmare disorder: State of the art and future perspectives
- PMID: 30697860
- PMCID: PMC6850667
- DOI: 10.1111/jsr.12820
Aetiology and treatment of nightmare disorder: State of the art and future perspectives
Abstract
This consensus paper provides an overview of the state of the art in research on the aetiology and treatment of nightmare disorder and outlines further perspectives on these issues. It presents a definition of nightmares and nightmare disorder followed by epidemiological findings, and then explains existing models of nightmare aetiology in traumatized and non-traumatized individuals. Chronic nightmares develop through the interaction of elevated hyperarousal and impaired fear extinction. This interplay is assumed to be facilitated by trait affect distress elicited by traumatic experiences, early childhood adversity and trait susceptibility, as well as by elevated thought suppression and potentially sleep-disordered breathing. Accordingly, different treatment options for nightmares focus on their meaning, on the chronic repetition of the nightmare or on maladaptive beliefs. Clinically, knowledge of healthcare providers about nightmare disorder and the delivery of evidence-based interventions in the healthcare system is discussed. Based on these findings, we highlight some future perspectives and potential further developments of nightmare treatments and research into nightmare aetiology.
Keywords: PTSD; anxiety; evidence-based medicine; exposure; imagery (psychotherapy); nightmare scripts; parasomnias; posttraumatic stress disorders; sleep-disorders.
© 2019 The Authors. Journal of Sleep Research published by John Wiley & Sons Ltd on behalf of European Sleep Research Society.
Conflict of interest statement
Anne Germain owns equity in and serves as CEO for Rehat, LLC and received a consulting honorarium from Jazz Pharmaceuticals. Barry Krakow sells products and services for the treatment of nightmares via his website and owns and operates the commercial sleep center Maimonides Sleep Arts & Sciences, Ltd. Annika Gieselmann, Malik Ait Aoudia, Michelle Carr, Robert Gorzka, Brigitte Holzinger, Birgit Kleim, Anna E. Kunze, Jaap Lancee, Michael R. Nadorff, Tore Nielsen, Dieter Riemann, Hinuga Sandahl, Angelika A. Schlarb, Carolin Schmid, Michael Schredl, Victor I. Spoormaker, Regina Steil, Annette M. van Schagen, Lutz Wittmann, Maria Zschoche and Reinhard Pietrowsky declare that they do not have any conflict of interests.
Figures
Comment in
-
The pathophysiology of nightmare disorder: Signs of impaired sleep regulation and hyperarousal.J Sleep Res. 2019 Dec;28(6):e12867. doi: 10.1111/jsr.12867. Epub 2019 May 15. J Sleep Res. 2019. PMID: 31094047 No abstract available.
-
Sleep, insomnia and neurological and mental disorders.J Sleep Res. 2019 Aug;28(4):e12892. doi: 10.1111/jsr.12892. J Sleep Res. 2019. PMID: 31297929 No abstract available.
References
-
- Agargün, M. Y. , Kara, H. , Bilici, M. , Çilli, A. S. , Telci, M. , Semiz, Ü. B. , & Başoğlu, C. (1999). The Van Dream Anxiety Scale: A subjective measure of dream anxiety in nightmare sufferers. Sleep and Hypnosis, 1, 204–211.
-
- American Academy of Sleep Medicine (AASM) (2014). International classification of sleep disorders – third edition. ICSD‐3. Darien, IL: AASM.
-
- American Psychiatric Association (APA) (1994). Diagnostic and statistical manual of mental disorders. DSM‐IV. Washington, DC: American Psychiatric Press.
-
- American Psychiatric Association (APA) (2013). Diagnostic and statistical manual of mental disorders. DSM‐5. Arlington, VA: American Psychiatric Publishing.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
